APA Zitierstil

LUZ, P. M., GRINSZTEJN, B., VELOSO, V. G., & PALTIEL, A. D. (2016). Yes, genotype testing is cost-effective for primary resistance in Brazil. J Acquir Immune Defic Syndr.

Chicago Zitierstil

LUZ, Paula M., Beatriz GRINSZTEJN, Valdilea G. VELOSO, und A. David PALTIEL. "Yes, Genotype Testing Is Cost-effective for Primary Resistance in Brazil." J Acquir Immune Defic Syndr 2016.

MLA Zitierstil

LUZ, Paula M., Beatriz GRINSZTEJN, Valdilea G. VELOSO, und A. David PALTIEL. "Yes, Genotype Testing Is Cost-effective for Primary Resistance in Brazil." J Acquir Immune Defic Syndr 2016.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.